pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
513
stories
Aug 11, 26
Breathing Circuit Set Recall: Hamilton Medical Removes Breathing Circuit Set
fda medwatch
Aug 11, 26
Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles
fda medwatch
Aug 10, 26
Tenax shares nosedive as heart failure drug fails in Phase 3
biospace
Aug 10, 26
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs
biospace
Aug 10, 26
STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study
stat
Aug 10, 26
ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
fiercebiotech
Aug 10, 26
Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
fiercebiotech
Aug 10, 26
Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program
fiercebiotech
Aug 10, 26
aTyr lays off 60% of workforce to fund 2nd attempt at phase 3 success for lung disease drug
fiercebiotech
Aug 7, 26
Opinion: Fauci doesn’t have the answers on Covid’s origins. China does
stat
Aug 7, 26
Why Big Pharma is chasing the industry’s most-powerful supercomputer
biopharma dive
Aug 7, 26
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
Aug 6, 26
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
Aug 6, 26
Sanofi pauses mid-stage lung study amid new CEO’s ‘rigorous portfolio prioritization’
biospace
Aug 6, 26
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
Aug 6, 26
Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock
biospace
Aug 6, 26
Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
fiercebiotech
Aug 6, 26
Medline Industries, LP Issues Nationwide Recall of Hudson RCI Neonatal/Infant Heated Wire Breathing Circuits
fda medwatch
Aug 5, 26
Attovia adds to biotech IPO momentum with $289M offering
biopharma dive
Aug 5, 26
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
biopharma dive
Aug 5, 26
No deal between AstraZeneca and BMS, senior source insists: Reuters
biospace
Aug 5, 26
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
fiercebiotech
Aug 5, 26
A COPD drug from China draws $115M in venture funding
biopharma dive
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
5 NextGen winners who went public this year (and which ones are hiring)
biospace
Aug 5, 26
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
fda medwatch
Aug 4, 26
Merck plans trial of sac-TMT combo with Keytruda in lung cancer
endpoints
Aug 4, 26
Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
biospace
Aug 4, 26
J&J pharma leader to retire; Krystal slumps on gene therapy miss
biopharma dive
Aug 4, 26
As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger
biospace
← prev
page 9 of 18
next →
